TY  - GEN
AU  - Fradet,Vincent
AU  - Toren,Paul
AU  - Nguile-Makao,Molière
AU  - Lodde,Michele
AU  - Lévesque,Jérome
AU  - Léger,Caroline
AU  - Caron,André
AU  - Bergeron,Alain
AU  - Ben-Zvi,Tal
AU  - Lacombe,Louis
AU  - Pouliot,Frédéric
AU  - Tiguert,Rabi
AU  - Dujardin,Thierry
AU  - Fradet,Yves
TI  - Prognostic value of urinary prostate cancer antigen 3 (PCA3) during active surveillance of patients with low-risk prostate cancer receiving 5α-reductase inhibitors
SN  - 1464-410X
PY  - 2018///0313
KW  - 5-alpha Reductase Inhibitors
KW  - therapeutic use
KW  - Aged
KW  - Antigens, Neoplasm
KW  - urine
KW  - Dutasteride
KW  - Finasteride
KW  - Follow-Up Studies
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Neoplasm Grading
KW  - Prospective Studies
KW  - Prostatic Neoplasms
KW  - pathology
KW  - Risk Factors
KW  - Single-Blind Method
KW  - Watchful Waiting
KW  - methods
N1  - Publication Type: Clinical Trial, Phase II; Journal Article
UR  - https://doi.org/10.1111/bju.14041
ER  -